表紙
市場調査レポート

大腸癌:パイプライン製品の分析

Colorectal Cancer - Pipeline Review, H2 2015

発行 Global Markets Direct 商品コード 232768
出版日 ページ情報 英文 1511 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。
Back to Top
大腸癌:パイプライン製品の分析 Colorectal Cancer - Pipeline Review, H2 2015
出版日: 2015年12月31日 ページ情報: 英文 1511 Pages
概要

大腸癌は、結腸または直腸から発生し始める癌で、その症状には、下痢や便秘、血便、激しい腹痛、満腹感や膨満感、原因不明の体重減、倦怠感、悪心、嘔吐などがあります。大腸癌を罹患する原因としては、喫煙、2型糖尿病、大腸癌を発症しやすい家系などが挙げられます。

当レポートでは、大腸癌治療薬におけるパイプライン製品の概要や治験の段階別の製品概要、主要企業のプロファイル、薬剤のプロファイル、パイプライン製品の最新動向などを提供しています。

イントロダクション

  • 調査範囲

大腸癌の概要

治療薬の開発

  • パイプライン製品の概要
  • パイプライン製品の比較分析

大腸癌:企業で開発中の治療薬

大腸癌:大学/機関で研究中の治療薬

大腸癌:パイプライン製品の概況

  • 後期段階の製品
  • 臨床段階の製品
  • 初期段階の製品
  • 開発段階が不明の製品

大腸癌:企業で開発中の製品

大腸癌:大学/機関で研究中の製品

大腸癌の治療薬開発に従事している企業

大腸癌:治療薬の評価

  • 単剤製品
  • 併用製品
  • 標的別
  • 作用機序別
  • 投与経路別
  • 分子タイプ別

薬剤プロファイル

大腸癌:最近のパイプライン動向

大腸癌:休止中のプロジェクト

大腸癌:開発が中止された製品

大腸癌:製品開発のマイルストーン

  • 主なニュースとプレスリリース

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC7196IDB

Summary

Global Markets Direct's, 'Colorectal Cancer - Pipeline Review, H2 2015', provides an overview of the Colorectal Cancer's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Colorectal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Colorectal Cancer and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Colorectal Cancer
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Colorectal Cancer and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Colorectal Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Colorectal Cancer pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products

Reasons to buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Colorectal Cancer
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Colorectal Cancer pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents

  • Table of Contents
  • Introduction
  • Colorectal Cancer Overview
  • Therapeutics Development
  • Colorectal Cancer - Therapeutics under Development by Companies
  • Colorectal Cancer - Therapeutics under Investigation by Universities/Institutes
  • Colorectal Cancer - Pipeline Products Glance
  • Colorectal Cancer - Products under Development by Companies
  • Colorectal Cancer - Products under Investigation by Universities/Institutes
  • Colorectal Cancer - Companies Involved in Therapeutics Development
  • Colorectal Cancer - Therapeutics Assessment
  • Drug Profiles
  • Colorectal Cancer - Recent Pipeline Updates
  • Colorectal Cancer - Dormant Projects
  • Colorectal Cancer - Discontinued Products
  • Colorectal Cancer - Product Development Milestones
  • Appendix

List of Tables

  • Number of Products under Development for Colorectal Cancer, H2 2015
  • Number of Products under Development for Colorectal Cancer - Comparative Analysis, H2 2015
  • Number of Products under Development by Companies, H2 2015
  • Number of Products under Development by Companies, H2 2015 (Contd..1)
  • Number of Products under Development by Companies, H2 2015 (Contd..2)
  • Number of Products under Development by Companies, H2 2015 (Contd..3)
  • Number of Products under Development by Companies, H2 2015 (Contd..4)
  • Number of Products under Development by Companies, H2 2015 (Contd..5)
  • Number of Products under Development by Companies, H2 2015 (Contd..6)
  • Number of Products under Development by Companies, H2 2015 (Contd..7)
  • Number of Products under Development by Companies, H2 2015 (Contd..8)
  • Number of Products under Development by Companies, H2 2015 (Contd..9)
  • Number of Products under Development by Companies, H2 2015 (Contd..10)
  • Number of Products under Development by Companies, H2 2015 (Contd..11)
  • Number of Products under Development by Companies, H2 2015 (Contd..12)
  • Number of Products under Development by Companies, H2 2015 (Contd..13)
  • Number of Products under Development by Companies, H2 2015 (Contd..14)
  • Number of Products under Development by Companies, H2 2015 (Contd..15)
  • Number of Products under Development by Companies, H2 2015 (Contd..16)
  • Number of Products under Development by Companies, H2 2015 (Contd..17)
  • Number of Products under Investigation by Universities/Institutes, H2 2015
  • Number of Products under Investigation by Universities/Institutes, H2 2015 (Contd..1)
  • Number of Products under Investigation by Universities/Institutes, H2 2015 (Contd..2)
  • Comparative Analysis by Late Stage Development, H2 2015
  • Comparative Analysis by Clinical Stage Development, H2 2015
  • Comparative Analysis by Early Stage Development, H2 2015
  • Comparative Analysis by Unknown Stage Development, H2 2015
  • Products under Development by Companies, H2 2015
  • Products under Development by Companies, H2 2015 (Contd..1)
  • Products under Development by Companies, H2 2015 (Contd..2)
  • Products under Development by Companies, H2 2015 (Contd..3)
  • Products under Development by Companies, H2 2015 (Contd..4)
  • Products under Development by Companies, H2 2015 (Contd..5)
  • Products under Development by Companies, H2 2015 (Contd..6)
  • Products under Development by Companies, H2 2015 (Contd..7)
  • Products under Development by Companies, H2 2015 (Contd..8)
  • Products under Development by Companies, H2 2015 (Contd..9)
  • Products under Development by Companies, H2 2015 (Contd..10)
  • Products under Development by Companies, H2 2015 (Contd..11)
  • Products under Development by Companies, H2 2015 (Contd..12)
  • Products under Development by Companies, H2 2015 (Contd..13)
  • Products under Development by Companies, H2 2015 (Contd..14)
  • Products under Development by Companies, H2 2015 (Contd..15)
  • Products under Development by Companies, H2 2015 (Contd..16)
  • Products under Development by Companies, H2 2015 (Contd..17)
  • Products under Development by Companies, H2 2015 (Contd..18)
  • Products under Development by Companies, H2 2015 (Contd..19)
  • Products under Development by Companies, H2 2015 (Contd..20)
  • Products under Development by Companies, H2 2015 (Contd..21)
  • Products under Development by Companies, H2 2015 (Contd..22)
  • Products under Development by Companies, H2 2015 (Contd..23)
  • Products under Investigation by Universities/Institutes, H2 2015
  • Products under Investigation by Universities/Institutes, H2 2015 (Contd..1)
  • Products under Investigation by Universities/Institutes, H2 2015 (Contd..2)
  • Colorectal Cancer - Pipeline by 2cureX ApS, H2 2015
  • Colorectal Cancer - Pipeline by 3-V Biosciences, Inc., H2 2015
  • Colorectal Cancer - Pipeline by 4SC AG, H2 2015
  • Colorectal Cancer - Pipeline by AB Science SA, H2 2015
  • Colorectal Cancer - Pipeline by AbbVie Inc., H2 2015
  • Colorectal Cancer - Pipeline by AbGenomics International, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Actinium Pharmaceuticals, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Adamed Sp. z o.o., H2 2015
  • Colorectal Cancer - Pipeline by Advaxis, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Advenchen Laboratories, LLC, H2 2015
  • Colorectal Cancer - Pipeline by Alchemia Limited, H2 2015
  • Colorectal Cancer - Pipeline by Allinky Biopharma, H2 2015
  • Colorectal Cancer - Pipeline by Amgen Inc., H2 2015
  • Colorectal Cancer - Pipeline by Antibe Therapeutics, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Apexigen, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Aphios Corporation, H2 2015
  • Colorectal Cancer - Pipeline by Aposense Ltd., H2 2015
  • Colorectal Cancer - Pipeline by Arisaph Pharmaceuticals, Inc., H2 2015
  • Colorectal Cancer - Pipeline by ArQule, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Array BioPharma Inc., H2 2015
  • Colorectal Cancer - Pipeline by Astellas Pharma Inc., H2 2015
  • Colorectal Cancer - Pipeline by Astex Pharmaceuticals, Inc., H2 2015
  • Colorectal Cancer - Pipeline by AstraZeneca Plc, H2 2015
  • Colorectal Cancer - Pipeline by ATLAB Pharma SAS, H2 2015
  • Colorectal Cancer - Pipeline by AVEO Pharmaceuticals, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Basilea Pharmaceutica AG, H2 2015
  • Colorectal Cancer - Pipeline by Bavarian Nordic A/S, H2 2015
  • Colorectal Cancer - Pipeline by Baxalta Incorporated, H2 2015
  • Colorectal Cancer - Pipeline by Bayer AG, H2 2015
  • Colorectal Cancer - Pipeline by BeiGene(Beijing) Co.,Ltd, H2 2015
  • Colorectal Cancer - Pipeline by BioAtla, LLC, H2 2015
  • Colorectal Cancer - Pipeline by Biocon Limited, H2 2015
  • Colorectal Cancer - Pipeline by Bionomics Limited, H2 2015
  • Colorectal Cancer - Pipeline by Bionovis SA, H2 2015
  • Colorectal Cancer - Pipeline by Biotecnol, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Biothera, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Boehringer Ingelheim GmbH, H2 2015
  • Colorectal Cancer - Pipeline by Boston Biomedical, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Bristol-Myers Squibb Company, H2 2015
  • Colorectal Cancer - Pipeline by Burzynski Research Institute, Inc., H2 2015
  • Colorectal Cancer - Pipeline by cCAM Biotherapeutics Ltd., H2 2015
  • Colorectal Cancer - Pipeline by CCRP Therapeutics GmbH, H2 2015
  • Colorectal Cancer - Pipeline by Celator Pharmaceuticals, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Celgene Corporation, H2 2015
  • Colorectal Cancer - Pipeline by Cellceutix Corporation, H2 2015
  • Colorectal Cancer - Pipeline by Celldex Therapeutics, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Cellectar Biosciences, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Celltrion, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Celon Pharma Sp. z o.o., H2 2015
  • Colorectal Cancer - Pipeline by Chipscreen Biosciences Ltd, H2 2015
  • Colorectal Cancer - Pipeline by Cleave Biosciences, H2 2015
  • Colorectal Cancer - Pipeline by Coare Biotechnology, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Cornerstone Pharmaceuticals, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Critical Outcome Technologies Inc., H2 2015
  • Colorectal Cancer - Pipeline by CritiTech, Inc., H2 2015
  • Colorectal Cancer - Pipeline by CrystalGenomics, Inc., H2 2015
  • Colorectal Cancer - Pipeline by CTI BioPharma Corp., H2 2015
  • Colorectal Cancer - Pipeline by Cytune Pharma SAS, H2 2015
  • Colorectal Cancer - Pipeline by Daiichi Sankyo Company, Limited, H2 2015
  • Colorectal Cancer - Pipeline by DanDrit Biotech A/S, H2 2015
  • Colorectal Cancer - Pipeline by Deciphera Pharmaceuticals, LLC, H2 2015
  • Colorectal Cancer - Pipeline by Dicerna Pharmaceuticals, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Digna Biotech, S.L., H2 2015
  • Colorectal Cancer - Pipeline by Double Bond Pharmaceutical International AB, H2 2015
  • Colorectal Cancer - Pipeline by Dr. Reddy's Laboratories Limited, H2 2015
  • Colorectal Cancer - Pipeline by EirGenix Inc., H2 2015
  • Colorectal Cancer - Pipeline by Eisai Co., Ltd., H2 2015
  • Colorectal Cancer - Pipeline by Eli Lilly and Company, H2 2015
  • Colorectal Cancer - Pipeline by Endor Nanotechnologies SL, H2 2015
  • Colorectal Cancer - Pipeline by enGene, Inc, H2 2015
  • Colorectal Cancer - Pipeline by EnGeneIC Ltd, H2 2015
  • Colorectal Cancer - Pipeline by Ensol Biosciences Inc., H2 2015
  • Colorectal Cancer - Pipeline by EntreChem, S.L., H2 2015
  • Colorectal Cancer - Pipeline by Enzo Biochem, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Epirus Biopharmaceuticals, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Erytech Pharma SA, H2 2015
  • Colorectal Cancer - Pipeline by Etubics Corporation, H2 2015
  • Colorectal Cancer - Pipeline by Exelixis, Inc., H2 2015
  • Colorectal Cancer - Pipeline by F. Hoffmann-La Roche Ltd., H2 2015
  • Colorectal Cancer - Pipeline by Five Prime Therapeutics, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Fusion Antibodies Limited, H2 2015
  • Colorectal Cancer - Pipeline by Genentech, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Genor BioPharma Co., Ltd., H2 2015
  • Colorectal Cancer - Pipeline by Genoscience Pharma, H2 2015
  • Colorectal Cancer - Pipeline by Genzyme Corporation, H2 2015
  • Colorectal Cancer - Pipeline by GlaxoSmithKline Plc, H2 2015
  • Colorectal Cancer - Pipeline by Glycotope GmbH, H2 2015
  • Colorectal Cancer - Pipeline by Golden Biotechnology Corp., H2 2015
  • Colorectal Cancer - Pipeline by Green Cross Corporation, H2 2015
  • Colorectal Cancer - Pipeline by Hadasit Medical Research Services & Development Ltd, H2 2015
  • Colorectal Cancer - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H2 2015
  • Colorectal Cancer - Pipeline by Hemispherx Biopharma, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Hetero Drugs Limited, H2 2015
  • Colorectal Cancer - Pipeline by Hospira, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Hutchison MediPharma Limited, H2 2015
  • Colorectal Cancer - Pipeline by iDD biotech SAS, H2 2015
  • Colorectal Cancer - Pipeline by Ignyta, Inc., H2 2015
  • Colorectal Cancer - Pipeline by immatics biotechnologies GmbH, H2 2015
  • Colorectal Cancer - Pipeline by Immodulon Therapeutics Ltd., H2 2015
  • Colorectal Cancer - Pipeline by ImmuneXcite, Inc., H2 2015
  • Colorectal Cancer - Pipeline by ImmunNovative Developments SL, H2 2015
  • Colorectal Cancer - Pipeline by Immunomedics, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Immunovative Therapies, Ltd., H2 2015
  • Colorectal Cancer - Pipeline by Inbiopro Solutions Pvt. Ltd., H2 2015
  • Colorectal Cancer - Pipeline by Incanthera Ltd., H2 2015
  • Colorectal Cancer - Pipeline by Incyte Corporation, H2 2015
  • Colorectal Cancer - Pipeline by Innovent Biologics, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Interprotein Corporation, H2 2015
  • Colorectal Cancer - Pipeline by Ionis Pharmaceuticals, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Isofol Medical AB, H2 2015
  • Colorectal Cancer - Pipeline by ISU ABXIS Co.,Ltd., H2 2015
  • Colorectal Cancer - Pipeline by Jiangsu Hengrui Medicine Co., Ltd., H2 2015
  • Colorectal Cancer - Pipeline by Kadmon Corporation, LLC, H2 2015
  • Colorectal Cancer - Pipeline by KAEL-GemVax Co., Ltd., H2 2015
  • Colorectal Cancer - Pipeline by KaloBios Pharmaceuticals, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Kancera AB, H2 2015
  • Colorectal Cancer - Pipeline by Karyopharm Therapeutics, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Kura Oncology, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Kyowa Hakko Kirin Co., Ltd., H2 2015
  • Colorectal Cancer - Pipeline by Laboratorio Elea S.A.C.I.F. and A, H2 2015
  • Colorectal Cancer - Pipeline by Lee's Pharmaceutical Holdings Limited, H2 2015
  • Colorectal Cancer - Pipeline by LivTech, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Loxo Oncology, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Mabion SA, H2 2015
  • Colorectal Cancer - Pipeline by Mabtech Limited, H2 2015
  • Colorectal Cancer - Pipeline by mAbxience S.A., H2 2015
  • Colorectal Cancer - Pipeline by MacroGenics, Inc., H2 2015
  • Colorectal Cancer - Pipeline by MedImmune, LLC, H2 2015
  • Colorectal Cancer - Pipeline by Medivation, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Merck & Co., Inc., H2 2015
  • Colorectal Cancer - Pipeline by Merck KGaA, H2 2015
  • Colorectal Cancer - Pipeline by Merrimack Pharmaceuticals, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Merus B.V., H2 2015
  • Colorectal Cancer - Pipeline by Millennium Pharmaceuticals, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Mirna Therapeutics, Inc., H2 2015
  • Colorectal Cancer - Pipeline by MolMed S.p.A., H2 2015
  • Colorectal Cancer - Pipeline by Mologen AG, H2 2015
  • Colorectal Cancer - Pipeline by Momenta Pharmaceuticals, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Morphotek, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Multimmune GmbH, H2 2015
  • Colorectal Cancer - Pipeline by Mycenax Biotech Inc., H2 2015
  • Colorectal Cancer - Pipeline by Natco Pharma Limited, H2 2015
  • Colorectal Cancer - Pipeline by NatureWise Biotech & Medicals Corporation, H2 2015
  • Colorectal Cancer - Pipeline by Nektar Therapeutics, H2 2015
  • Colorectal Cancer - Pipeline by Neovacs SA, H2 2015
  • Colorectal Cancer - Pipeline by Nerviano Medical Sciences S.r.l., H2 2015
  • Colorectal Cancer - Pipeline by Nippon Kayaku Co., Ltd., H2 2015
  • Colorectal Cancer - Pipeline by NormOxys, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Northwest Biotherapeutics, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Novartis AG, H2 2015
  • Colorectal Cancer - Pipeline by NuCana BioMed Limited, H2 2015
  • Colorectal Cancer - Pipeline by OBI Pharma, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Oncobiologics, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Oncology Research International Limited, H2 2015
  • Colorectal Cancer - Pipeline by Oncolytics Biotech Inc., H2 2015
  • Colorectal Cancer - Pipeline by OncoMed Pharmaceuticals, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Onconova Therapeutics, Inc., H2 2015
  • Colorectal Cancer - Pipeline by Oncothyreon Inc., H2 2015
  • Colorectal Cancer - Pipeline by Oryx GmbH & Co. KG, H2 2015
  • Colorectal Cancer - Pipeline by Otsuka Holdings Co., Ltd., H2 2015
  • Colorectal Cancer - Pipeline by Oxford BioMedica Plc, H2 2015
  • Colorectal Cancer - Pipeline by Panacea Biotec Limited, H2 2015
  • Colorectal Cancer - Pipeline by Pfizer Inc., H2 2015
  • Colorectal Cancer - Pipeline by Pharma Mar, S.A., H2 2015

List of Figures

  • Number of Products under Development for Colorectal Cancer, H2 2015
  • Number of Products under Development for Colorectal Cancer - Comparative Analysis, H2 2015
  • Number of Products under Development by Companies, H2 2015
  • Number of Products under Investigation by Universities/Institutes, H2 2015
  • Comparative Analysis by Late Stage Development, H2 2015
  • Comparative Analysis by Clinical Stage Development, H2 2015
  • Comparative Analysis by Early Stage Products, H2 2015
  • Assessment by Monotherapy Products, H2 2015
  • Assessment by Combination Products, H2 2015
  • Number of Products by Top 10 Targets, H2 2015
  • Number of Products by Stage and Top 10 Targets, H2 2015
  • Number of Products by Top 10 Mechanism of Actions, H2 2015
  • Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015
  • Number of Products by Top 10 Routes of Administration, H2 2015
  • Number of Products by Stage and Top 10 Routes of Administration, H2 2015
  • Number of Products by Top 10 Molecule Types, H2 2015
  • Number of Products by Stage and Top 10 Molecule Types, H2 2015
Back to Top